close
Sucess

Great! You have sucessfully subscribed for newsletters for investments

Subscribed email:

Compare Mutual Funds

 
  • Category,
    Sub-category
  • equity, sectoral-pharma
  • equity, sectoral-pharma
  • ET Money Rank in sub-category
  • N.A.
  • N.A.
  • Fund Age
  • 3 yrs 9 m
  • 6 yrs 8 m
  • Fund Size
  • ₹221 Cr
  • ₹2,961 Cr
  • 3 months
  • 13.0%
  • 13.3%
  • 6 months
  • -3.7%
  • -4.21%
  • 1 year
  • 14.17%
  • 15.5%
  • 3 year
  • 24.24%
  • 28.25%
  • 5 year
  • NA
  • 25.24%
  • Standard Deviation
  • 15.42
  • 14.68
  • Sharpe
  • 1.07
  • 1.35
  • Beta
  • 0.95
  • 0.85
  • Sortino
  • 1.49
  • 2.22
  • Alpha
  • -2.12
  • 3.1
  • Top 3 sectors
    • Healthcare (93.84%)
    • Chemicals (3.6399999999999997%)
    • Services (1.29%)
    • Healthcare (97.52%)
    • Insurance (1.53%)
    • Unclassified (0.55%)
  • Top 5 holdings
    • Sun Pharmaceutical Industries Ltd. (15.18%)
    • Divi's Laboratories Ltd. (9.12%)
    • Max Healthcare Institute Ltd. (5.42%)
    • Lupin Ltd. (5.4%)
    • Apollo Hospitals Enterprise Ltd. (5.19%)
    • Cipla Ltd. (8.86%)
    • Cohance Lifesciences Ltd. (8.81%)
    • Sun Pharmaceutical Industries Ltd. (8.7%)
    • Ipca Laboratories Ltd. (8.16%)
    • Gland Pharma Ltd. (4.94%)
  • Equity%
  • 99.7%
  • 99.6%
  • Debt%
  • 0.0%
  • 0.0%
  • Turnover Ratio
  • NA
  • NA
  • Yield To Maturity
  • NA
  • NA
  • Modified Duration
  • NA
  • NA
  • Avg. Maturity
  • NA
  • NA
  • Avg. Credit Quality
  • NA
  • NA
  • Expense Ratio
  • 2.35%
  • 0.62%
  • Exit Load
  • 0.5% know more
  • 0.5% know more
  • Lock-in
  • No Lockin
  • No Lockin
  • Benchmark Index
  • NIFTY Healthcare TRI.
  • BSE Healthcare TRI
  • Min. Investment
  • NA
  • SIP ₹500 & Lumpsum ₹500
  • Investment Horizon
  • Good for Long Term
  • Good for Long Term
  • Managed By
    • Rohan Korde
    • Dhimant Shah
    • Chirag Dagli
Go to top